Search Results - the VM202 study group
- Showing 1 - 1 results of 1
-
1
Gene therapy for diabetic peripheral neuropathy: A randomized, placebo‐controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor by John A. Kessler, Aziz Shaibani, Christine N. Sang, Mark Christiansen, David Kudrow, Aaron Vinik, Nari Shin, the VM202 study group
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book